环丙沙星治疗腹泻患者后大肠杆菌抗菌药物敏感性率的变化
Posttreatment changes in Escherichia coli antimicrobial susceptibility rates among diarrheic patients treated with ciprofloxacin.
作者信息
Putnam Shannon D, Sanders John W, Tribble David R, Rockabrand David R, Riddle Mark S, Rozmajzl Patrick J, Frenck Robert W
机构信息
Naval Medical Research Unit 2, Jakarta, Indonesia.
出版信息
Antimicrob Agents Chemother. 2005 Jun;49(6):2571-2. doi: 10.1128/AAC.49.6.2571-2572.2005.
Abstract
Changes in antimicrobial resistance of Escherichia coli among deployed U.S. military personnel being treated for diarrhea were evaluated. Stool samples were collected pretreatment and on days 7, 14, and 28 posttreatment. Resistance to ciprofloxacin was noted in 13.3% of baseline specimens, and rates of resistance against multiple antibiotics increased dramatically from baseline to day 7 and then tapered off to return to pretreatment levels by day 28, except for ciprofloxacin, suggesting that population accumulative usage of fluoroquinolones may result in an incremental increase in resistance rates.
摘要
对正在接受腹泻治疗的美国现役军人中大肠杆菌的抗菌药物耐药性变化进行了评估。在治疗前以及治疗后第7天、14天和28天采集粪便样本。在13.3%的基线样本中发现对环丙沙星耐药，除环丙沙星外，多重抗生素耐药率从基线到第7天急剧上升，然后逐渐下降，到第28天恢复到治疗前水平，这表明氟喹诺酮类药物的人群累积使用可能导致耐药率逐步上升。
相似文献
1
Posttreatment changes in Escherichia coli antimicrobial susceptibility rates among diarrheic patients treated with ciprofloxacin.环丙沙星治疗腹泻患者后大肠杆菌抗菌药物敏感性率的变化
Antimicrob Agents Chemother. 2005 Jun;49(6):2571-2. doi: 10.1128/AAC.49.6.2571-2572.2005.
2
Drug-resistant diarrheogenic Escherichia coli, Mexico.耐药性致泻性大肠杆菌，墨西哥
Emerg Infect Dis. 2005 Aug;11(8):1306-8. doi: 10.3201/eid1108.050192.
3
Resistance Pattern and Molecular Characterization of Enterotoxigenic Escherichia coli (ETEC) Strains Isolated in Bangladesh.孟加拉国分离的产肠毒素大肠杆菌（ETEC）菌株的耐药模式及分子特征
PLoS One. 2016 Jul 18;11(7):e0157415. doi: 10.1371/journal.pone.0157415. eCollection 2016.
4
Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.从土耳其社区获得性尿路感染中分离出的大肠杆菌菌株对环丙沙星耐药的危险因素。
J Antimicrob Chemother. 2005 Nov;56(5):914-8. doi: 10.1093/jac/dki344. Epub 2005 Sep 20.
5
Prevalence and Antimicrobial Resistance Patterns of Diarrheagenic Escherichia coli in Shanghai, China.中国上海致泻性大肠杆菌的流行情况及耐药模式
Pediatr Infect Dis J. 2016 Aug;35(8):835-9. doi: 10.1097/INF.0000000000001190.
6
Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates.尿源性大肠杆菌分离株对环丙沙星耐药的危险因素
J Microbiol Immunol Infect. 2008 Aug;41(4):325-31.
7
8
Clinical consequences of increased ciprofloxacin and gentamicin resistance in patients with Escherichia coli bacteraemia in the Netherlands.荷兰大肠杆菌菌血症患者中对环丙沙星和庆大霉素耐药性增加的临床后果。
Scand J Infect Dis. 2012 May;44(5):363-8. doi: 10.3109/00365548.2011.641506. Epub 2011 Dec 27.
9
E. coli Resistance to Ciprofloxacin and Common Associated Factors.大肠杆菌对环丙沙星的耐药性及常见相关因素
J Coll Physicians Surg Pak. 2015 Nov;25(11):824-7.
10
Antimicrobial resistance and molecular characterization of virulence genes, phylogenetic groups of Escherichia coli isolated from diarrheic and healthy camel-calves in Tunisia.突尼斯腹泻和健康骆驼犊中分离出的大肠杆菌的抗菌药物耐药性、毒力基因的分子特征及系统发育群
Comp Immunol Microbiol Infect Dis. 2016 Dec;49:1-7. doi: 10.1016/j.cimid.2016.08.008. Epub 2016 Aug 31.
引用本文的文献
1
Efficacy of ciprofloxacin in an experimental model of Escherichia coli chorioamnionitis in rabbits.环丙沙星在兔大肠杆菌性绒毛膜羊膜炎实验模型中的疗效
Antimicrob Agents Chemother. 2009 Apr;53(4):1624-7. doi: 10.1128/AAC.00186-08. Epub 2009 Jan 21.
本文引用的文献
1
Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.美国重症监护病房革兰氏阴性杆菌的抗生素耐药性：对氟喹诺酮类药物使用的影响
JAMA. 2003 Feb 19;289(7):885-8. doi: 10.1001/jama.289.7.885.
2
An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection.一项针对部署在泰国的美国军事人员腹泻疾病的基于诊所的观察性研究：弯曲杆菌感染的表现与转归。
Am J Trop Med Hyg. 2002 Nov;67(5):533-8. doi: 10.4269/ajtmh.2002.67.533.
3
4
Riddle of biofilm resistance.生物膜抗性之谜。
Antimicrob Agents Chemother. 2001 Apr;45(4):999-1007. doi: 10.1128/AAC.45.4.999-1007.2001.
5
Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance.利用集中体外检测和电子监测评估氟喹诺酮类药物目前对革兰氏阴性杆菌的抗菌活性。
Antimicrob Agents Chemother. 2001 Jan;45(1):267-74. doi: 10.1128/AAC.45.1.267-274.2001.
6
Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora.氟喹诺酮类药物给药对胃肠道菌群中耐氟喹诺酮革兰氏阴性杆菌出现的影响。
Clin Infect Dis. 2001 Jan;32(1):162-6. doi: 10.1086/317551. Epub 2000 Dec 11.
7
Empirical antimicrobial therapy for traveler's diarrhea.旅行者腹泻的经验性抗菌治疗。
Clin Infect Dis. 2000 Oct;31(4):1079-83. doi: 10.1086/318119. Epub 2000 Oct 25.
8
Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections.口服抗生素治疗尿路感染对人体正常微生物群的影响。
J Antimicrob Chemother. 2000 Aug;46 Suppl A:41-48.
9
Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin.抗生素渗透限制在肺炎克雷伯菌生物膜对氨苄西林和环丙沙星耐药中的作用
Antimicrob Agents Chemother. 2000 Jul;44(7):1818-24. doi: 10.1128/AAC.44.7.1818-1824.2000.
10
Impact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes.
Clin Infect Dis. 1999 May;28(5):1017-24. doi: 10.1086/514747.
Zotero 插件